Expired Canadian patentCanada
Epha2 antigen t epitopes
CA 2482930 C · Owner: Institut National De La Sante Et De La Recherche Medicale · Inventors: Kosmatopoulos, Kostas; Alves, Pedro
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns peptides constituting T epitopes of EphA antigen exhibited by MHC I. Said peptides are useful in particular in antitumoral immunotherapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 23, 2003 and granted August 13, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 23, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 23, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 23, 2003
GrantedAugust 13, 2013
Term endedApril 23, 2023
Patent numberCA 2482930 C
Classification (IPC)C12N9/12 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.